In Figures 7A–D, after adjusting for variables such as the age, ECOG PS score, first presenting symptoms, tumor location, surgical resection, and therapy status, the results indicated that HRS was an independent prognostic factor, regardless of an IDH-mutant or IDH-wild-type status. This evidence concerns the gene IDH2 and neoplasm.